|
84
|
305
|
7ta7A |
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 10/11 |
|
0
|
8
|
7t9yC |
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 8/9 |
|
82
|
302
|
7tixA |
Crystal structure of sars-cov-2 3cl in complex with inhibitor eb56 |
|
85
|
305
|
7tb2A |
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 12/13 |
|
86
|
303
|
7tiaA |
Crystal structure of sars-cov-2 3cl in complex with inhibitor nk01-14 |
|
87
|
303
|
7ta4A |
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 9/10 |
|
87
|
304
|
7t8rA |
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 7/8 |
|
87
|
305
|
7t8mA |
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 5/6 |
|
88
|
302
|
7tiyA |
Crystal structure of sars-cov-2 3cl in complex with inhibitor nk01-48 |
|
80
|
305
|
7t70A |
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 4/5 |
|
0
|
10
|
7tbtB |
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 13/14 |
|
79
|
302
|
7t9yA |
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 8/9 |
|
0
|
8
|
7tb2B |
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 12/13 |
|
86
|
303
|
7tiwA |
Crystal structure of sars-cov-2 3cl in complex with inhibitor eb54 |
|
84
|
303
|
7tizA |
Crystal structure of sars-cov-2 3cl in complex with inhibitor nk01-63 |
|
0
|
9
|
7t8mC |
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 5/6 |
|
83
|
301
|
7tj0A |
Crystal structure of sars-cov-2 3cl in complex with inhibitor sl-4-241 |
|
271
|
947
|
7s7bA |
Human nuclear exosome targeting (next) complex homodimer bound to rna (substrate 1) |
|
17
|
102
|
7sgtA |
Domain iii (ediii) of the powv e glycoprotein |
|
91
|
298
|
7r1tA |
Crystal structure of sars-cov-2 nsp10/nsp16 in complex with the ss148 inhibitor |
|
71
|
305
|
7qt8A |
Room temperature in-situ sars-cov-2 mpro with bound abt-957 |
|
29
|
113
|
7r1uB |
Crystal structure of sars-cov-2 nsp10/nsp16 in complex with the wz16 inhibitor |
|
75
|
304
|
7qt9A |
Room temperature in-situ sars-cov-2 mpro with bound z4439011584 |
|
77
|
304
|
7qt6A |
Room temperature in-situ sars-cov-2 mpro with bound z1367324110 |
|
28
|
113
|
7r1tB |
Crystal structure of sars-cov-2 nsp10/nsp16 in complex with the ss148 inhibitor |
|
74
|
304
|
7qt7A |
Room temperature in-situ sars-cov-2 mpro with bound z4439011520 |
|
90
|
297
|
7r1uA |
Crystal structure of sars-cov-2 nsp10/nsp16 in complex with the wz16 inhibitor |
|
71
|
305
|
7qt5A |
Room temperature in-situ sars-cov-2 mpro with bound z31792168 |
|
76
|
305
|
7p2gA |
Identification of low micromolar sars-cov-2 mpro inhibitors from hits identified by in silico screens |
|
120
|
387
|
7ppzB |
Crystal structure of the burkholderia lethal factor 1 (blf1) c94s inactive mutant in complex with human eif4a - crystal form a |
|
126
|
385
|
7pq0B |
Crystal structure of the burkholderia lethal factor 1 (blf1) c94s inactive mutant in complex with human eif4a - crystal form b |
|
79
|
302
|
7mb9A |
Sars-cov-2 main protease (mpro) c145a in complex with cleavage site nsp10/11 (p6-p1) |
|
97
|
259
|
7fjtA |
Crystal structure of omsk hemorrhagic fever virus ns5 mtase (in complex with sam) |
|
82
|
305
|
7mb8A |
Sars-cov-2 main protease (mpro) c145a in complex with cleavage site nsp8/9 (p6-p1) |
|
74
|
305
|
7mb6A |
Sars-cov-2 main protease (mpro) c145a in complex with cleavage site nsp6/7 (p6-p1) |
|
80
|
305
|
7mb4A |
Sars-cov-2 main protease (mpro) c145a in complex with cleavage site nsp4/5 (p6-p1) |
|
81
|
305
|
7mb5A |
Sars-cov-2 main protease (mpro) c145a in complex with cleavage site nsp5/6 (p6-p1) |
|
0
|
6
|
7mb7B |
Sars-cov-2 main protease (mpro) c145a in complex with cleavage site nsp7/8 (p6-p1) |
|
80
|
302
|
7mb7A |
Sars-cov-2 main protease (mpro) c145a in complex with cleavage site nsp7/8 (p6-p1) |
|
65
|
167
|
5srvA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z5198562533 - (r,r) isomer |
|
67
|
167
|
5sqlA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z2689779890 |
|
67
|
167
|
5ssnA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z5010894382 - (r,s) isomer |
|
66
|
167
|
5sqbA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z5010894390 - (r,r) and (s,s) isomers |
|
66
|
167
|
5sq6A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z5010894406 |
|
66
|
167
|
5sq0A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with real300007260658 - (s,s) isomer |
|
65
|
167
|
5sr9A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z3562259556 - (r) isomer |
|
64
|
167
|
5srzA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z5281440906 - (r,s) and (s,r) isomers |
|
62
|
167
|
5squA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with real250004627335 |
|
65
|
167
|
5srqA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z3831836449 - (r) isomer |
|
64
|
167
|
5srtA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z5198562791 - (r) isomer |
